CCM
FOLD

Convector Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Convector Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$752K Sell
101,600
-104,400
-51% -$705K 1.38% 25
2016
Q2 		$1.13M Sell
206,000
-28,400
-12% -$199K 1.55% 20
2016
Q1 		$1.98M Buy
234,400
+23,900
+11% +$169K 2% 18
2015
Q4 		$2.04M Buy
+210,500
New +$1.9M 1.92% 17

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Convector Capital Management's FOLD Position: Q3 2016 in Review

Convector Capital Management reduced its Amicus Therapeutics (FOLD) stake by 51% in Q3 2016, selling an estimated $705K and leaving 101,600 shares worth $752K. The position accounts for 1.38% of the portfolio, ranked #25.

Convector Capital Management first reported a position in FOLD in Q4 2015 and has held it in 4 quarters since. The position peaked at $2.04M in Q4 2015. 136 funds tracked by Wall St. Rank hold FOLD as of Q3 2016.

  • Convector Capital Management held 101,600 shares of Amicus Therapeutics worth $752K as of Q3 2016.
  • Convector Capital Management sold 104,400 Amicus Therapeutics shares in Q3 2016, an estimated $705K.
  • Amicus Therapeutics made up 1.38% of Convector Capital Management's portfolio in Q3 2016, its #25 holding.
  • Convector Capital Management first reported a position in Amicus Therapeutics in Q4 2015 and has held it in 4 quarters since.
  • Convector Capital Management's Amicus Therapeutics position peaked at $2.04M in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2016.

Based on Convector Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.